Open Study of Intravenous Recombinant Hirudin (CGP 39393) on Platelet Function and Coagulation in Healthy Volunteers

This publication has 26 references indexed in Scilit:

• Clinical Pharmacology of Intravenously Administered Recombinant Desulfatohirudin (CGP 39393) in Healthy Volunteers
  Journal of Cardiovascular Pharmacology, 1993
• Hirudin, contrary to heparin, does not induce platelet adhesion to blood clots and extracellular matrix in vitro
  Journal of the American College of Cardiology, 1991
• Antithrombotic and haemorrhagic effects of synthetic and naturally occurring thrombin inhibitors
  Thrombosis Research, 1986
• A thromboxane synthetase inhibitor reorients endoperoxide metabolism in whole blood towards prostacyclin and prostaglandin E2
  Thrombosis Research, 1982
• Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo
  Blood, 1981
• The effect of hirudin on endotoxin induced disseminated intravascular coagulation (DIC)
  Thrombosis Research, 1980
• The use of immobilized ligands and [125I] protein a for immunoassays of thromboxane B2, prostaglandin D2, 13,14-dihydro-prostaglandin E2, 5,6-dihydro-prostaglandin I2, 6-keto-prostaglandin F1α, 15-hydroxy-9α,11α(epoxymethano)prosta5, 13-dienoic acid and 15-hydroxy-11α,9α(epoxymethano)prosta-5,13-dienoic acid
  Prostaglandins and Medicine, 1979
• Development and Evaluation of a Disposable Device for Performing Simultaneous Duplicate Bleeding Time Determinations
  American Journal of Clinical Pathology, 1978
• The release, distribution, and clearance of human β-thromboglobulin and platelet factor 4
  Thrombosis Research, 1978
• The aggregation of blood platelets
  The Journal of Physiology, 1963